Deep learning-driven morphology analysis enables label-free classification of therapeutic agent- naive versus resistant cancer cells
Cyril Y. Ramathal, Kiran Saini, Zhouyang Lian, Christian Corona, Tiffine Pham, Ryan Carelli, Stéphane C. Boutet, Manisha Ray, Sunantha Sethuraman, Vivian Prindle, Evelyn Lattmann, Maria-Grazia Molvetti, Andreas Dzung, Mitchell Paul Levesque, Matt Barnes, Andreja Jovic
This study uses deep learning to classify drug-naive and resistant cancer cells based on morphology, achieving high accuracy across multiple cancer types and drug classes.
bioRxiv · Jan 22, 2025 · PreprintCancer Biology